BioSpace News Archive

electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today provided an operating and business update as well as select unaudited preliminary financial guidance for the third quarter of 2021.

BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA:NPAU ), is pleased to announce early positive in vitro results from Dr. Stephen Barr’s Laboratory at the state-of-the-art ImPaKT Facility at the Schulich School of Medicine & Dentistry, Western University, Ontario.

Applied Genetic Technologies Corporation today announced Sue Washer, President and Chief Executive Officer of AGTC, will present at the 2021 Cell & Gene Management Meeting on the Mesa being held October 12-14, 2021.

IntelGenx Corp. (TSX:IGX) (OTCQB:IGXT) (“IntelGenx” or the “Company”)), a leader in pharmaceutical films, today announced its intention to resume patient screening in the ongoing Montelukast VersaFilm® Phase 2a (“BUENA”) clinical trial in patients with mild to moderate Alzheimer’s Disease (“AD”) following Health Canada’s (“HC”) issuance of a No Objection Letter (“NOL”) in response to IntelGenx’s amended Clinical Trial Application.

Excision BioTherapeutics Inc., a biotechnology company developing CRISPR-based therapies intended to cure viral infectious diseases, today announced the expansion of its management team with the appointments of Sara Turken, J.D., as General Counsel, Manish Anand, M.Sc., as Senior Vice President, Regulatory Affairs, and Robert Gunning, CPA, CGMA, as VP, Controller.

Krystal Biotech, Inc. today announced a collaboration offering no-charge genetic testing for all types of Epidermolysis Bullosa (EB).

CinCor Pharma, Inc. (“CinCor”) today announced the completion of a $143 million Series B financing.

Coya Therapeutics, Inc. (Coya), a clinical-stage biotechnology company developing first-in-class approaches utilizing autologous regulatory T cells (Treg) and Treg-derived exosome therapeutics for neurodegenerative and autoimmune diseases, today announced the appointment of Gene Mack as Chief Financial Officer effective immediately.

BioCardia®, Inc. announced the issuance of U.S. Patent No: 11,141,568 for “Multi Directional Steerable Catheter” that further protects the Helix™ Biotherapeutic Delivery System and enhances its biotherapeutic delivery capabilities.

InnerScope Hearing Technologies Inc. announces the appointment of Adnan Shennib as chief technology officer.